Stay updated on NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.

Latest updates to the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record now states 'No longer looking for participants', indicating recruitment is closed. New navigation items and sections such as How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment were added, while the old 'Intervention / Treatment' formatting and the revision tag were updated to v3.6.0.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays revision v3.5.5, indicating a small site update was applied. This change is administrative and does not alter study information or visible content.SummaryDifference0.0%

- Check43 days agoChange DetectedAdds a new Clin Cancer Res. 2026 publication citation for 'Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer' to the NADIM II Publications section and removes the earlier Clin Cancer Res. 2026 Mar 10 reference. This update reflects an upgrade to the study's listed publications, aligning with the most current literature cited in the trial record.SummaryDifference0.1%

- Check57 days agoChange DetectedNADIM II recruitment sites in Spain were updated, adding new locations and addresses while removing several previous sites to reflect a revised geographic footprint for participant enrollment.SummaryDifference4%

- Check71 days agoChange DetectedRevision: v3.5.2 was added to the page, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.